Fed Spend Map

Glaxosmithkline, LLCFederal contracts and grants

The headline uses obligations in FY2026. FY2027 is year to date. Award value and outlays are different measures. Read the fiscal-year example.

  • Durham, NC
  • UEI FRHTPHMZMX47
  • Parent: Glaxosmithkline PLC

USAspending shows $4.1B in obligations to this recipient in each of the 5 fiscal years from FY2023 to FY2027.

The obligations in FY2026 were $1.1B.

Contracts were $40M of the obligations in FY2026.

The obligations in FY2027 to date are $59M.

The awards of $1 million or more that started since FY2023 came from 2 agencies.

The largest award value came from the Department of Health and Human Services.

By obligations since FY2023, it is number 266 of 66,594 listed recipients, and number 5 of 1,425 in North Carolina.

Its obligations rose by 8.3% from FY2025 to FY2026, and those of all listed recipients fell by 2.9%.

Contracts were 3.8% of its obligations in FY2026, and 78% of the obligations of the recipients with contracts of $1 million or more.

Places of performanceAward value since FY2023

The states where the work of the awards of $1 million or more is done. The swatches go from the smallest award value to the largest. The largest is North Carolina: $112M.

North Carolina: the address of the recipient.

The amounts for each state. Outlines: US Census Bureau.

An outlay occurs when federal money is actually paid out, not just promised to be paid ("obligated").

Procurement data (such as for contracts and indefinite delivery vehicles (IDV)) for the Department of Defense (DOD) and U.S. Army Corps of Engineers (USACE) are published on a 90-day delay in the Federal Procurement Data System (FPDS).

Maintaining data quality for the award description field has been persistently challenging for federal agencies.

These are the words of USAspending. Sources: USAspending.gov, About the Data (PDF, last updated 19 November 2025) and USAspending.gov, Glossary. The site copied them on .

The amounts on this page are obligations. An obligation is a promise to pay. It is not a payment. Contract records of the Department of Defense come late, so a recent month can be low. The text under a name in a list of awards is the description that the agency wrote.

USAspending loaded the data on . USAspending profile of this recipient

Since the last update

The site recorded a change on .

  • Obligations in FY2027 to date changed from under $1 million to $59M.

All changes of 28 Oct 2026

Obligations by fiscal year

Obligations to Glaxosmithkline, LLC by fiscal yearA fiscal year starts on 1 October. "Under $1 million" is a year below the listing floor: the amount is not zero, and the site does not list it. FY2027 runs from 1 October 2026 to 30 September 2027. USAspending loaded these data on 16 Nov 2026, so the figures of FY2027 stop on that date.
Fiscal yearAll obligationsContractsOther awards
FY2023$843M$13M$831M
FY2024$1.2B$63M$1.1B
FY2025$980M$30M$951M
FY2026$1.1B$40M$1.0B
FY2027 to date$59Munder $1 million$59M

Contracts are the procurement award types. Other awards are grants, direct payments, loans (subsidy cost) and other assistance. The contracts figure shows only when contracts alone are $1 million or more.

Business types on USAspending: Corporation, Foreign-owned.

Awarding agencies

Agencies that gave awards of $1 million or more to Glaxosmithkline, LLCAwards that started in FY2023 or later, by award value, largest first.
AgencyAwardsAward valueShare
Department of Health and Human Services13$125M98%
Department of Defense2$2.9M2%

Awards

The newest awards of $1 million or more to Glaxosmithkline, LLCNewest first. The text under the agency is the description on USAspending.
Awarding agencyTypeIndustry or programAward valueStart datePlaceRecord
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseContractDefinitive Contract325412 Pharmaceutical Preparation Manufacturing$27M26 Sep 2025NCUSAspending
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseContractDelivery Order541714 Research and Development in Biotechnology (except Nanobiotechnology)$8.8M13 Jun 2025NCUSAspending
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseContractDelivery Order541714 Research and Development in Biotechnology (except Nanobiotechnology)$1.7M23 Aug 2024NCUSAspending
Department of Health and Human ServicesIndian Health ServiceContractDelivery Order325412 Pharmaceutical Preparation Manufacturing$2.8M20 Jun 2024OKUSAspending
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseContractDelivery Order541714 Research and Development in Biotechnology (except Nanobiotechnology)$12M17 Jun 2024NCUSAspending
Awards of $1 million or more to Glaxosmithkline, LLC that started in FY2023 or laterBy award value, largest first. The award value is the amount obligated to the award to date. The site does not show a description that has the name of a person.
Awarding agencyTypeIndustry or programAward valueStart datePlaceRecord
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseRELENZA (ZANAMIVIR) ROTADISK, 5MGContractDefinitive Contract325412 Pharmaceutical Preparation Manufacturing$27M26 Sep 2025NCUSAspending
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseTHIS TASK ORDER ESTABLISHES SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION OF MEDICAL COUNTERMEASURES (MCMS) FOR PANDEMIC INFLUENZA AND EMERGING DISEASES ...ContractDelivery Order541714 Research and Development in Biotechnology (except Nanobiotechnology)$18M10 May 2024NCUSAspending
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseTHE PURPOSE OF THIS TASK ORDER IS TO ESTABLISH FILL/FINISH ACTIVITIES FOR ADJUVANT (AS03) TO SUPPORT THE COVID-19 FEDERAL RESPONSE- MULTI-DOSE VIALS FOR HHS ...ContractDelivery Order541714 Research and Development in Biotechnology (except Nanobiotechnology)$15M27 Feb 2024NCUSAspending
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseTHE PURPOSE OF THIS HHS TASK ORDER IS TO PROCURE SERVICES FOR THE STORAGE AND STABILITY OF BULK LOTS & FINAL CONTAINERS OF-ADJUVANT( AS03) COVID-19 FUNDS.ContractDelivery Order541714 Research and Development in Biotechnology (except Nanobiotechnology)$14M20 Feb 2024NCUSAspending
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseTHIS TASK ORDER ESTABLISHES SERVICES FOR STORAGE AND STABILITY OF AS03 ADJUVANT MANUFACTURED TO SUPPORT THE COVID-19 FEDERAL RESPONSE IN BULK LOTS AND FINAL ...ContractDelivery Order541714 Research and Development in Biotechnology (except Nanobiotechnology)$12M17 Jun 2024NCUSAspending
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseCLIN 1005, CGMP ADJUVANT: CLINICAL OR COMMERCIAL SCALE BULK LOT(S)ContractDelivery Order541714 Research and Development in Biotechnology (except Nanobiotechnology)$8.8M13 Jun 2025NCUSAspending
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseRELENZA (ZANAMIVIR) ROTADISK, SMG, NDC 00173-0681-22ContractDelivery Order325412 Pharmaceutical Preparation Manufacturing$8.7M16 Aug 2023GAUSAspending
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseTHE PURPOSE OF THIS TASK ORDER IS TO PROCURE STORAGE AND STABILITY FOR ANTIGENS AND ADJUVANTS FROM PRIOR CONTRACTS FOR THE DEPARTMENT OF HEALTH AND HUMAN ...ContractDelivery Order541714 Research and Development in Biotechnology (except Nanobiotechnology)$7.8M20 Feb 2024NCUSAspending
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponsePURPOSE OF THIS MODIFICATION IS TO: 1. ACCEPT TRANSFER ACCOUNTABILITY OF 5,015,690 VIALS (50.1 MILLION DOSES) OF AS03 ADJUVANT FROM CONTRACT # W15QKN-20-C-0048 ...ContractDelivery Order541714 Research and Development in Biotechnology (except Nanobiotechnology)$4.7M12 Dec 2022PAUSAspending
Department of Health and Human ServicesIndian Health ServiceDELIVERY ORDER FOR ANNUAL FLU VACCINES FROM GLAXOSMITHKLINE LLCContractDelivery Order325412 Pharmaceutical Preparation Manufacturing$2.8M20 Jun 2024OKUSAspending
Department of Health and Human ServicesCenters for Disease Control and PreventionGSK VACCINES STORAGE AND ROTATION CONTRACTContractDelivery Order325411 Medicinal and Botanical Manufacturing$2.1M10 Aug 2023NCUSAspending
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseTHE PURPOSE OF THIS TASK ORDER IS TO PROCURE STORAGE AND STABILITY OF ANTIGENS AND ADJUVANTS FROM PRIOR CONTRACTS FOR DEPARTMENT OF HEALTH AND HUMAN SERVICES ...ContractDelivery Order541714 Research and Development in Biotechnology (except Nanobiotechnology)$2.0M17 Feb 2023NCUSAspending

Industries, programs and places of performance

States of the place of performanceAward value of the awards of $1 million or more, largest first. The place of performance is where the work is done.
StateAwardsAward value
North Carolina12$112M
Georgia1$8.7M
Pennsylvania1$4.7M
Oklahoma1$2.8M

The counties with the largest award value, largest first.

Other recipients of about the same size

Recipients in the same NAICS sector, with an address in North Carolina. In order of name. These recipients have obligations nearest to those of Glaxosmithkline, LLC in the listed fiscal years.

All recipients in North Carolina, in order of name.

Official records

Each link opens a page of a federal agency in a new tab. The site examined the links on .

Embed this card on your site

Copy this code into your page. The card shows the figures above with their source. A line under the card links to this page.

How embedding works. It is free. Keep the link in the card and the link line under it.

Cite this page

Fed Spend Map. "Glaxosmithkline, LLC: federal contracts and grants". Data: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, loaded .

https://fedspendmap.com/recipient/frhtphmzmx47-glaxosmithkline-llc/

The address of this page is permanent.

Where the figures come from

USAspending.gov API v2 (U.S. Department of the Treasury, Bureau of the Fiscal Service). Fiscal year obligations: the list of recipients by state, with a listing floor of $1 million for each year. Awards: the award search, new awards of $1 million or more by base obligation date. Parent and business types: the recipient profile.

USAspending loaded the data on 16 Nov 2026. A closed fiscal year is a copy made after the year end. The site shows organisations only. The site corrects an error in its own work at the next build. See how to report an error and how the atlas is made.

Questions

Which fiscal years are in the total?

The total has 5 fiscal years.

  • FY2023: $843M
  • FY2024: $1.2B
  • FY2025: $980M
  • FY2026: $1.1B
  • FY2027 to date: $59M

The site lists a fiscal year of a recipient when the obligations of the year are $1 million or more.

Which industries and programs do the awards name?

The contract awards of $1 million or more name 4 NAICS industries.

The largest award value is in NAICS 541714, Research and Development in Biotechnology (except Nanobiotechnology): $84M.

Where is the place of performance?

The awards of $1 million or more name 4 states as the place of performance.

The largest award value is in North Carolina: $112M.

The place of performance is where the work is done. It is not always the address of the recipient.

How many awards are in the lists on this page?

The lists hold 15 awards of $1 million or more that started in FY2023 or later.

Their award value is $128M.

An award under that amount is in the obligations of the fiscal years but not in the lists.